Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9837520 | PMC |
| http://dx.doi.org/10.1177/21925682221143437 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
International consensus statement on microbiome testing in clinical practice.
Lancet Gastroenterol Hepatol
February 2025
Department of Translational Medicine and Surgery, Università Cattolica del Sacro Cuore, Rome, Italy; Department of Medical and Surgical Sciences, UOC Gastroenterologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy. Electronic address:
There is growing interest in the potential exploitation of the gut microbiome as a diagnostic tool in medicine, but evidence supporting its clinical usefulness is scarce. An increasing number of commercial providers offer direct-to-consumer microbiome diagnostic tests without any consensus on their regulation or any proven value in clinical practice, which could result in considerable waste of individual and health-care resources and potential drawbacks in the clinical management of patients. We convened an international multidisciplinary expert panel to standardise best practices of microbiome testing for clinical implementation, including recommendations on general principles and minimum requirements for their provision, indications, pre-testing protocols, method of analyses, reporting of results, and potential clinical value.
View Article and Find Full Text PDFOral Semaglutide Use in Type 2 Diabetes: A Pooled Analysis of Clinical and Patient-Reported Outcomes from Seven PIONEER REAL Prospective Real-World Studies.
Diabetes Ther
January 2025
Division of Endocrinology and Metabolism, University of British Columbia, Vancouver, Canada.
Article Synopsis
- Oral semaglutide is a diabetes medication that improves blood sugar levels and has been evaluated in multiple countries through the PIONEER REAL program, focusing on its clinical and patient-reported outcomes.
- * In a pooled analysis of 1615 participants, significant reductions in glycated hemoglobin (HbA) by 1.0% and body weight by 5.0% were observed after 38 weeks of treatment, along with increased treatment satisfaction.
- * The analysis revealed that shorter duration of type 2 diabetes was associated with greater improvements in HbA and body weight, while no significant age-related effects were found on clinical outcomes.
Monoclonal antibodies: From magic bullet to precision weapon.
Mol Biomed
October 2024
Department of Pharmacognosy, Faculty of Pharmacy and Drug Technology, Egyptian Chinese University (ECU), Cairo, Egypt.
Article Synopsis
- * The development of mAbs has evolved from murine antibodies to humanized versions, significantly reducing side effects while offering targeted treatments; however, their high production costs remain a challenge.
- * Innovations like biosimilar antibodies and advancements in antibody engineering are enhancing the effectiveness and affordability of mAbs, potentially transforming drug therapies and addressing unmet medical needs.
How Metarhizium robertsii's mycelial consciousness gets its conidia Zen-ready for stress.
Adv Appl Microbiol
October 2024
Inbioter-Institute of Biotechnology Rangel, Caixa Postal 5, Itatiba, SP, Brazil. Electronic address:
Article Synopsis
- The memoir chronicles the author's journey in fungal stress research, particularly focusing on the insect-pathogenic fungus Metarhizium robertsii, showcasing how it turned dreams into reality.
- With guidance from renowned advisors at Utah State University, the author experiences thrilling moments of discovery and intense dedication to research, often working 18 hours a day.
- The memoir also highlights the creation of the International Symposium on Fungal Stress, which has grown to attract international attention, featuring 162 speakers from 29 countries, and is set to celebrate its fifth edition in 2024.
Correction to: MR beyond diagnostics at the ESMRMB annual meeting: MR theranostics and intervention.
MAGMA
October 2024
Max-Delbrück-Centrum Für Molekulare Medizin (MDC), Berlin Ultrahigh Field Facility, Berlin, Germany.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!